000 00878 a2200229 4500
005 20250515150557.0
264 0 _c20111110
008 201111s 0 0 eng d
022 _a1205-7088
024 7 _a10.1093/pch/12.5.373
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCheng, Anita
245 0 0 _aThe impact of the withdrawal of Adderall XR (long-acting mixed amphetamine salts) from the Canadian market on paediatric patients and their families.
_h[electronic resource]
260 _bPaediatrics & child health
_cMay 2007
300 _a373-8 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aTithecott, Gary A
700 1 _aEdwards, Wendy E
700 1 _aJohnston, Ian G
773 0 _tPaediatrics & child health
_gvol. 12
_gno. 5
_gp. 373-8
856 4 0 _uhttps://doi.org/10.1093/pch/12.5.373
_zAvailable from publisher's website
999 _c18486492
_d18486492